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lation corresponds to participating subjects since 2004 who received continuous
annual follow-up visits until 2009. The trend analysis of the different risk factors
over time was performed, as well as the estimate of the annual CVR using ATPIII
categories (High, moderate and lower risk). RESULTS: 3,870 subjects were included
in the assessment with a mean age of 62 years (SD11.52) and the majority of
subjects are women (73%). The results showed a reduction of 30% in smoking. In
addition, over the past 5 years, blood pressure (BP) diminished consistently
through risk groups (mean reduction of 14 mmHg); LDL cholesterol levels were
reduced within high and moderate risk groups (mean reduction of 25 mg/dl) and
the speed of kidney damage progression decreased. Complementary analyses with
an extended cohort containing over 8,000 patients exhibited similar results.
CONCLUSIONS: Cardiovascular Risk DM Program “De Todo Corazón” showed a
meaningful impact to modify risk factors in Colombian patients such as smoking,
BP, lipid profile and kidney risk. The results of a wider cohort supported that ob-
served positive outcomes trends were generated by this program.
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OBJECTIVES:Todetermine the health care utilization andpotential cost savings for
an employer-sponsored medication therapy management (MTM) program.
METHODS: A prospective, pre-post longitudinal study. Employees included in the
study were Lucas County employees and their dependents who had diabetes, hy-
pertension, hyperlipidemia, or a combination of the three. The MTM services were
provided by independent pharmacists from seven sites in Northwest Ohio. Vari-
ables measured included social measures (alcohol consumption, tobacco con-
sumption, exercise, caffeine consumption) and process measures (specialty phy-
sician visits, sick days, emergency room visits, flu shot, hypoglycemic events, and
self-monitoring of blood glucose). Difference in disease-related spending, pre-and
post joining MTM program were analyzed for employees who improved, did not
improve or showed negative improvement at their final recorded visit for process
measures. Data was analyzed using SPSS v17.0 and Microsoft Excel. RESULTS:
There was an overall trend of improvement in both the social and process mea-
sures being measured. All three specialty physician visits have increased: podia-
trist visits by 24%, ophthalmologist visits by 41%, and dentist visits by 26%. Average
cost savings for employees who improved or maintained appropriate utilization,
ranged from $931.67 to $1437.77 per employee per two years. Approximately 90% of
employees either took less or had the same amount of sick days. Employees who
had fewer sick days saved almost $1230.79 per employee while employees who
took more sick days spent approximately $2146.51 per employee. Employee utili-
zation of flu shots have been substantial, with 70% getting a flu shot at least once
over the 24 months. Alcohol and tobacco consumption decreased by 50% and 55%,
respectively. Caffeine use decreased by 26.47%. Reported exercise increased by
39%. CONCLUSIONS: Interaction with the pharmacist has had a positive impact on
employees’ outcomes related to social and process measures, which might also be
helpful in causing reduction in cost burden to the employer.
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OBJECTIVES: To assess the impact of an employer-sponsored, pharmacist-pro-
vided MTM program on clinical outcomes in patients with diabetes and hyperten-
sion over a 24 month period. METHODS: A prospective, intent-to-treat, pre-post
longitudinal study. Patients were Lucas County employees and dependents with
diabetes, hypertension, or a combination. The MTM services were provided by
independent pharmacists in Northwest Ohio at seven sites. ADA and JNC-VII
guidelines were used to design interventions and set patient goals. Data was ana-
lyzed using SPSS v17.0. Friedman testwas used to compare readings at baseline, 12,
and 24months. RESULTS: To date 623 patients have enrolled in the MTM program,
41 with diabetes only, 224 with diabetes and one or more comorbidities, 85 with
hypertension only, and 101 with hypertension with comorbidities. A total of 190
patients with A1C values and 412 patients with blood pressure values were ana-
lyzed.MeanA1C values increased from 7.14 1.53 to 7.28 1.52 for all patients. For
uncontrolled patients, A1C decreased from 8.40  1.57 to 8.03  1.63. Diabetes
patients decreased systolic blood pressure (SBP) from 133.59  19.57 to 129.65 
16.04 and diastolic blood pressure (DBP) from 81.95  10.38 to 79.49  8.72. Uncon-
trolled patients decreased SBP from 147.65  16.62 to 134.02  14.99 and DBP de-
creased from 87.65  6.66 to 82.31  8.31. Hypertensive patients decreased SBP
from 134.42  17.28 to 129.86  14.13 and DBP from 84.76  10.97 to 81.76  10.10.
Uncontrolled hypertensive patients decreased SBP from 151.89  11.10 to 134.95 
12.56 and DBP from 98.27 6.24 to 85.71 11.86. CONCLUSIONS: The pharmacists’
efforts have been shown to help decrease mean A1C and BP in patients. The im-
provements in these values help to decrease the risk for related complications and
additional employer costs.
PCV82
EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL
AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN
PHYSICIAN ORGANIZATIONS
Smalarz A1, Fraser K1, Wong K2, Wu N1, Wogen J3, Boulanger L1
1United BioSource Corporation, Lexington, MA, USA, 2Novartis Pharmaceuticals Corporation,
East Hanover, NJ, USA, 3MedMentis Consulting, LLC, Towaco, NJ, USA
OBJECTIVES: To assess the relationship between integration of services and the
management of hypertensive patients within select physician organizations in the
U.S.METHODS:Amodified version of the Physician Practice Connection Readiness
Survey (PPC-RS), developed by the National Committee for Quality Assurance
(NCQA), was administered to chief medical officers at 28 U.S.-based physician or-
ganizations in 2010. The integration score included structural, functional, and fi-
nancial sub-domains with possible scores of 0 to 100; a higher score indicating
greater integration of services. Demographic and clinical data were collected from
a random sample of 300 hypertensive adults selected for chart review at each
participating organization. Site characteristics and integration scores were re-
ported. Hierarchical regression models were estimated to assess the association
between an organization’s integration score and patients’ outcomes. RESULTS: Of
the 28 participating sites, most had electronic medical records functions (71.4%)
and hadmore than 50 staffmembers (78.6%). The average integration scorewas 46,
with mean scores of 64, 33 and 42 for the structural, financial, and functional
sub-domains, respectively. Integration scores were generally higher in sites with
50 physicians as compared to sites with 50 physicians (52.8 vs. 36.6, respec-
tively), and were also higher in sites owned by hospitals. Among the 8,400 patients
reviewed, approximately 60.5% had controlled BP. A positive correlation was ob-
served between integration scores and controlled BP (Pearson coefficient  0.39,
p0.05). Additionally, patient BP control was better in organizations with integra-
tion scores in the highest quartile (64.3%) than in sites in the lowest quartile
(56.8%). Although the point estimates were not significant in the hierarchical
model, regression analyses suggested that higher integration scores were associ-
ated with better BP control outcomes. CONCLUSIONS: This study provides some
evidence that better integration of service in physician organizations is associated
with better patient outcomes as reported via the PPC-RS.
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OBJECTIVES: Antiplatelet therapies with aspirin, ADP receptor inhibitors, and gly-
coprotein IIb/IIIa inhibitors play an important role in management of acute coro-
nary syndromes and chronic coronary heart disease. An assessment of the litera-
ture was conducted to identify evidence gaps and critical unmet needs in
antiplatelet therapy in the management of ACS and chronic CHD. METHODS: A
targeted literature search was conducted on antiplatelet therapy with a focus on
ADP receptor inhibitors using PubMed, Medline and Google Scholar. Parallel
searches were initiated for the ACS and chronic CHD. Additional references were
identified and included based on citations from reviewed articles. A total of 179
articles were reviewed. Article types considered in the study included review arti-
cles, clinical trials, observational studies, and economic evaluations.RESULTS:The
review identified gaps and unmet needs in drug therapy for ACS and chronic CHD
using established (aspirin, clopidogrel, and glycoprotein IIb/IIIa agents) and newer
drugs (prasugrel and ticagrelor). Key evidentiary gapswere identified on the impact
of clopidogrel resistance, antiplatelet associatedmajor, minor and nuisance bleed-
ing risk, impact on humanistic outcomes, long term cost-effectiveness, impact on
elderly patients and other high risk subpopulations. Our assessment revealed that
current antiplatelet therapies are associated with significant downsides, such as
increased bleeding risks as well as other untoward effects. CONCLUSIONS: Our
assessment revealed important gaps and areas of unmet need associated with
current and new antiplatelet therapies in the management of ACS and chronic
CHD. Further studies should be conducted to address these evidentiary gaps, while
unmet patient needs should be taken into consideration in future drug develop-
ment.
PCV84
EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT
HYPERTENSION IN PRIMARY CARE
Martinez Valverde S1, Reyes Morales H2, Castro Rios A3, Perez Cuevas R3,
Klunder Klunder M1, Salinas Escudero G1
1Hospital Infantil de México Federico Gómez, Mexico City, D.F., Mexico, 2Instituto Nacional de
Salud Pública, Morelos, Mexico, 3Mexican Institute for Social Security (IMSS), Mexico City, D.F.,
Mexico
OBJECTIVES: To report the effectiveness of a CME intervention to improve appro-
priate care for hypertension, which in turn has a positive effect on blood pressure
control of hypertensive patients in primary care clinics. METHODS: A secondary
data analysis was carried out using data of hypertensive patients treated by family
doctors who participated in the CME intervention. The evaluation was designed as
a pre-/post-intervention study with control group in six primary care clinics. The
effect of the CME intervention was analysed using multiple logistic regression
modelling in which the dependent variable was uncontrolled blood pressure in the
postintervention patient measurement. The model was adjusted by considering
the family doctors as a cluster unit. This allowed correcting the effect of including
several patients who received treatment by the same doctor. Selection of regres-
sion variables was carried out by comparing 2 values of the log likelihood in the
models; this was carried out by using the backward stepwise procedure. Goodnes-
sof-fit of the model was evaluated using the Hosmer–Lemeshow test. RESULTS:
After the CME intervention, the net reduction of uncontrolled blood pressure be-
tween stages in the intervention group was 10.3%. The model results were that
being treated by a family doctor who participated in the CME intervention reduced
by 53% the probability of lack of control of blood pressure; receiving dietary recom-
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